Ian Kronborg

3.1k total citations
27 papers, 1.1k citations indexed

About

Ian Kronborg is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Ian Kronborg has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Hepatology and 5 papers in Physiology. Recurrent topics in Ian Kronborg's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Ian Kronborg is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Ian Kronborg collaborates with scholars based in Australia, United States and Italy. Ian Kronborg's co-authors include Harry Teichtahl, Olaf H. Drummer, David Wang, David Cunnington, Robert D. Zipser, George Daskalopoulos, Robert L. Peters, Giacomo Laffi, Stephen R. Bird and Timothy Quinnell and has published in prestigious journals such as Gastroenterology, Hepatology and CHEST Journal.

In The Last Decade

Ian Kronborg

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Kronborg Australia 18 329 315 254 250 231 27 1.1k
Denis Monneret France 20 123 0.4× 482 1.5× 305 1.2× 36 0.1× 45 0.2× 46 1.0k
Raymond Rault United States 18 242 0.7× 144 0.5× 26 0.1× 35 0.1× 91 0.4× 43 903
S. Cure United Kingdom 16 215 0.7× 51 0.2× 26 0.1× 211 0.8× 64 0.3× 39 565
Jong-Koo Kim South Korea 17 224 0.7× 128 0.4× 30 0.1× 28 0.1× 38 0.2× 47 697
Jan Börgel Germany 16 70 0.2× 621 2.0× 403 1.6× 9 0.0× 60 0.3× 25 1.2k
Horng‐Yih Ou Taiwan 14 333 1.0× 144 0.5× 31 0.1× 17 0.1× 34 0.1× 51 870
Kentaro Oniki Japan 20 214 0.7× 98 0.3× 27 0.1× 33 0.1× 29 0.1× 87 1.1k
Phillip Banks United States 24 622 1.9× 112 0.4× 44 0.2× 25 0.1× 22 0.1× 57 2.8k
Yung‐Chuan Lu Taiwan 17 173 0.5× 118 0.4× 27 0.1× 23 0.1× 12 0.1× 50 806
Niels Zeuthen Denmark 6 224 0.7× 811 2.6× 156 0.6× 39 0.2× 24 0.1× 17 2.7k

Countries citing papers authored by Ian Kronborg

Since Specialization
Citations

This map shows the geographic impact of Ian Kronborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Kronborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Kronborg more than expected).

Fields of papers citing papers by Ian Kronborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Kronborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Kronborg. The network helps show where Ian Kronborg may publish in the future.

Co-authorship network of co-authors of Ian Kronborg

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Kronborg. A scholar is included among the top collaborators of Ian Kronborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Kronborg. Ian Kronborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gow, Paul, Michael Fink, Anouk Dev, et al.. (2018). Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population‐based study. The Medical Journal of Australia. 209(8). 348–354. 43 indexed citations
2.
Kemp, William, Amanda Nicoll, Stuart K. Roberts, et al.. (2018). Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C. Journal of Hepatology. 69(3). 575–583. 24 indexed citations
3.
Doyle, Adam, Philip Marsh, Simone I. Strasser, et al.. (2016). Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study. Scandinavian Journal of Gastroenterology. 51(8). 979–985. 9 indexed citations
4.
Kemp, William, Anouk Dev, Sally Bell, et al.. (2016). Community Approach Targeting Cirrhosis and Hepatocellular Carcinoma – Catch. Journal of Hepatology. 64(2). S739–S740. 1 indexed citations
5.
Kazankov, Konstantin, Gerda Elisabeth Villadsen, Amanda Nicoll, et al.. (2015). Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma. Scandinavian Journal of Clinical and Laboratory Investigation. 76(1). 64–73. 30 indexed citations
6.
Sinclair, Marie, Stuart K. Roberts, William Kemp, et al.. (2012). Epidemiology of hepatitis B‐associated hepatocellular carcinoma in Victoria. Internal Medicine Journal. 43(5). 501–506. 6 indexed citations
7.
Boussioutas, Alex, et al.. (2011). Gastrointestinal: Tuberculosis of the sigmoid colon—a cautionary tale. Journal of Gastroenterology and Hepatology. 26(11). 1692–1692.
8.
Sasadeusz, Joseph, et al.. (2010). Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy. Addiction. 106(5). 977–984. 26 indexed citations
9.
Wang, David, et al.. (2008). Subjective Daytime Sleepiness and Daytime Function in Patients on Stable Methadone Maintenance Treatment: Possible Mechanisms. Journal of Clinical Sleep Medicine. 4(6). 557–562. 43 indexed citations
10.
Judd, Louise M., Trevelyan R. Menheniott, Ian Kronborg, et al.. (2007). Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression. The Journal of Pathology. 213(2). 140–151. 91 indexed citations
11.
Bird, Stephen R., et al.. (2007). Integrated care facilitation for older patients with complex health care needs reduces hospital demand. Australian Health Review. 31(3). 451–461. 61 indexed citations
12.
Wang, David, et al.. (2005). Central Sleep Apnea in Stable Methadone Maintenance Treatment Patients. CHEST Journal. 128(3). 1348–1356. 219 indexed citations
13.
Teichtahl, Harry, David Wang, David Cunnington, et al.. (2005). Ventilatory Responses to Hypoxia and Hypercapnia in Stable Methadone Maintenance Treatment Patients. CHEST Journal. 128(3). 1339–1347. 82 indexed citations
14.
Teichtahl, Harry, et al.. (2004). Cardiorespiratory function in stable methadone maintenance treatment (MMT) patients. Addiction Biology. 9(3-4). 247–253. 24 indexed citations
15.
Lubman, Dan I., et al.. (2003). Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users. Drug and Alcohol Review. 22(4). 433–436. 6 indexed citations
16.
Teichtahl, Harry, et al.. (2001). Sleep‐disordered breathing in stable methadone programme patients: a pilot study. Addiction. 96(3). 395–403. 116 indexed citations
17.
Uchida, Toshikazu, et al.. (1987). The characteristics of alcoholic liver disease in Japan. Clinicopathologic comparison with alcoholic liver disease in the United States. Liver International. 7(5). 290–297. 10 indexed citations
18.
Élie, R, et al.. (1986). Factors that determine refractoriness of ascites to conventional therapy.. PubMed. 135(5). 481–6. 6 indexed citations
19.
Daskalopoulos, George, et al.. (1985). Sulindac and Indomethacin Suppress the Diuretic Action of Furosemide in Patients With Cirrhosis and Ascites: Evidence That Sulindac Affects Renal Prostaglandins. American Journal of Kidney Diseases. 6(4). 217–221. 27 indexed citations
20.
Uchida, Toshikazu, Ian Kronborg, & Robert L. Peters. (1984). Alcoholic hyalin‐containing hepatocytes — a characteristic morphologic appearance. Liver International. 4(4). 233–243. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis Monneret Breakdown of academic impact, for papers by Raymond Rault Breakdown of academic impact, for papers by S. Cure Breakdown of academic impact, for papers by Jong-Koo Kim Breakdown of academic impact, for papers by Jan Börgel Breakdown of academic impact, for papers by Horng‐Yih Ou Breakdown of academic impact, for papers by Kentaro Oniki Breakdown of academic impact, for papers by Phillip Banks Breakdown of academic impact, for papers by Yung‐Chuan Lu Breakdown of academic impact, for papers by Niels Zeuthen
Rankless by CCL
2026